Skip to main content
Fig. 3 | Lipids in Health and Disease

Fig. 3

From: Homocysteine diminishes apolipoprotein A-I function and expression in patients with hypothyroidism: a cross-sectional study

Fig. 3

Apo A-I values in the study subgroups. n = 76 in the N-control group (control subjects with a plasma level of Hcy ≤ 15 μmol/l); n = 18 in the H-control group (control subjects with a plasma level of Hcy > 15 μmol/l); n = 59 in the N-SHO group (patients with SHO and a plasma level of Hcy ≤ 15 μmol/l); n = 32 in the H-SHO group (patients with SHO and a plasma level of Hcy > 15 μmol/l); n = 37 in the N-HO group (patients with HO and a plasma level of Hcy ≤ 15 μmol/l); n = 36 in the H-HO group (patients with HO and a plasma level of Hcy > 15 μmol/l)

Back to article page

Lipids in Health and Disease

ISSN: 1476-511X